Quest Capital Management Inc. ADV lessened its stake in shares of Cigna Corp (NYSE:CI) by 98.7% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,740 shares of the health services provider’s stock after selling 128,045 shares during the period. Quest Capital Management Inc. ADV’s holdings in Cigna were worth $274,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of CI. C J Advisory Inc purchased a new stake in Cigna during the 1st quarter valued at $40,000. TRUE Private Wealth Advisors purchased a new stake in Cigna during the 2nd quarter valued at $40,000. Trustcore Financial Services LLC purchased a new stake in Cigna during the 1st quarter valued at $49,000. Baldwin Brothers Inc. MA purchased a new stake in Cigna during the 1st quarter valued at $50,000. Finally, First Personal Financial Services boosted its stake in Cigna by 78.5% during the 1st quarter. First Personal Financial Services now owns 341 shares of the health services provider’s stock valued at $55,000 after purchasing an additional 150 shares during the last quarter. 87.64% of the stock is owned by institutional investors.
Several brokerages have commented on CI. Zacks Investment Research downgraded Cigna from a “buy” rating to a “hold” rating and set a $164.00 target price on the stock. in a research note on Tuesday, June 11th. Goldman Sachs Group downgraded Cigna from a “conviction-buy” rating to a “buy” rating in a research note on Friday, May 3rd. Citigroup cut their target price on Cigna from $228.00 to $203.00 and set a “buy” rating on the stock in a research note on Monday, June 3rd. ValuEngine downgraded Cigna from a “hold” rating to a “sell” rating in a research note on Tuesday, July 23rd. Finally, Morgan Stanley dropped their price target on Cigna from $241.00 to $207.00 and set an “overweight” rating on the stock in a research note on Friday, July 12th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $214.55.
Cigna (NYSE:CI) last released its quarterly earnings results on Thursday, August 1st. The health services provider reported $4.30 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.74 by $0.56. The firm had revenue of $34.38 billion for the quarter, compared to the consensus estimate of $33.27 billion. Cigna had a return on equity of 13.24% and a net margin of 3.60%. The company’s revenue for the quarter was up 198.9% on a year-over-year basis. During the same period last year, the business posted $3.89 EPS. On average, equities research analysts anticipate that Cigna Corp will post 16.75 earnings per share for the current fiscal year.
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Recommended Story: Holder of Record
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.